Bioteque Corporation (TPEX:4107)

Market Cap	9.08B
Revenue (ttm)	2.09B
Net Income (ttm)	499.22M
Shares Out	69.30M
EPS (ttm)	7.17
PE Ratio	18.27
Forward PE	17.42
Dividend	4.50 (3.61%)
Ex-Dividend Date	Jul 30, 2024

Volume	268,264
Average Volume	71,186
Open	125.00
Previous Close	124.50
Day's Range	125.00 - 131.50
52-Week Range	114.00 - 147.50
Beta	0.46
RSI	71.13
Earnings Date	Mar 14, 2025

About Bioteque

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine c...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2023, Bioteque's revenue was 1.94 billion, a decrease of -3.26% compared to the previous year's 2.01 billion. Earnings were 452.55 million, a decrease of -8.31%.